Study Summary
This triallooks at how an area of the brain affects how we make decisions.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
2 Primary · 0 Secondary · Reporting Duration: 1 hour after intervention
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
TMS targeting anterior OFC networks
1 of 2
TMS targeting posterior OFC networks
1 of 2
Experimental Treatment
60 Total Participants · 2 Treatment Groups
Primary Treatment: TMS targeting anterior OFC networks · No Placebo Group · N/A
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18 - 40 · All Participants · 3 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Frequently Asked Questions
Are there any available slots for participants in this trial?
"Affirmative. According to information hosted on clinicaltrials.gov, this medical trial is still recruiting participants after its initial posting date of July 18th 2022 and subsequent update from October 14th 2022. The research requires 60 subjects from a single center." - Anonymous Online Contributor
How many subjects are engaged in this investigation?
"Affirmative, according to clinicaltrials.gov the trial was launched on July 18th 2022 and recently updated as of October 14th 2022, with a goal to enroll 60 patients from one dedicated medical centre." - Anonymous Online Contributor
Does the research group accept minors for their trial?
"The parameters set for this study require that interested participants must be between 18 and 40 years of age. Conversely, there are 50 trials available for those under the age of majority and 371 specifically catered to individuals aged 65 or older." - Anonymous Online Contributor
Are the qualifications for this research project compatible with my profile?
"This trial is seeking approximately 60 individuals between 18 and 40 years of age with healthy bodies. Participants must satisfy these criteria to be accepted into this clinical research project." - Anonymous Online Contributor